SECsense Logo

Voyager Therapeutics 8-K Report: Key Insights & SEC Compliance Overview

$VYGR
Form 8-K
Filed on: 2025-02-11
Source
Voyager Therapeutics 8-K Report: Key Insights & SEC Compliance Overview

Based on the provided XML section of a financial report, here are the key insights and important information extracted:

  1. Entity Information:
  • Name: Voyager Therapeutics, Inc.
  • CIK: 0001640266
  • State of Incorporation: Delaware (DE)
  • SEC File Number: 001-37625
  • EIN: 46-3003182
  • Address: 75 Hayden Avenue, Lexington, MA 02421
  • Phone Number: 857-259-5340
  1. Filing Type:
  • Type: 8-K
  • Filing Date: February 11, 2025
  1. Stock Information:
  • Common Stock Par Value: $0.001
  • Ticker Symbol: VYGR
  • Exchange: NASDAQ
  1. Reporting Context:
  • Report Date: As of February 11, 2025
  • Measurement Units:
    • Financial reports are expressed in USD.
    • Shares are also referenced as a unit of measure.
  1. Key Dates:
  • Start Date of Report Period: February 11, 2025
  • End Date of Report Period: February 11, 2025

This information is crucial for understanding the company’s compliance with SEC reporting requirements, the nature of its securities, and the specifics of the filing itself.